Alternative Stent Supply Agreement Violated By Medinol - BSX Countersuit
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific is charging Israeli stent partner Medinol with violating their supply agreement by failing to provide chemical etching services that would benefit an alternative stent line sanctioned by the deal.